Stock Taper
SCREENER COMPARE ANY 2 STOCKS
XCUR
EXICURE, INC.
NASDAQ
$1.29
▼ DOWN 8.51% (-0.12)

KEY STATISTICS

Market Cap$8.22 M
52w High$9.48
52w Low$1.05
Dividend Yield—
Frequency—
P/E-0.98
Volume18.87K
Shares Out.6.37M

COMPANY

LEADERSHIP

Jungsoo Kim
CHIEF EXECUTIVE
Jungsoo Kim

COMPENSATION 2026

Salary$150,000
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$20,000
Total$170,000

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 22, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
8

PRICE TARGET

Target High$12.00
Target Low$12.00
Target Median$12.00
Target Consensus$12.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$1.55M
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2024-08-28Reverse1:5
2022-06-30Reverse1:30

PRICE

$1.29 ▼ DOWN 8.51% (−$0.12)
OVERLAYS
$1.32$1.35$1.389:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.29

About Exicure, Inc.

https://www.exicuretx.com ↗

Exicure, Inc. is a Chicago-based biotech company developing SNA-based therapies for neurological disorders and hair loss, with collaborations with AbbVie and Ipsen.

INDUSTRY

Biotechnology

A PRODUCT EXICURE, INC. IS KNOWN FOR

Burixafor (GPC-100)
Burixafor (GPC-100)

Burixafor is a Phase 2 clinical-stage small molecule CXCR4 antagonist developed by Exicure to enhance stem cell mobilization in multiple myeloma patients undergoing autologous transplant.

COMPETITORS

COMPETITOR
BLRX COMPARE
CRIS COMPARE
KPTI COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 28.9K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
54.45%
HOLDERS
27
TOP 12 OF 27 · RANKED BY POSITION SIZE
Broadfin Capital, LLC
2.7M sh · $7.74M
Abingworth Llp
281.6K sh · $323.88K
Carlyle Group Inc.
281.6K sh · $1.13M
Vanguard Group Inc
42.0K sh · $227.88K
Fairpointe Capital LLC
38.0K sh · $83K
Geode Capital Management, LLC
36.9K sh · $157.64K
Private Vista, LLC
34.9K sh · $86K
Ubs Group AG
18.7K sh · $76.49K
Northern Trust Corp
10.7K sh · $45.46K
Blackrock, Inc.
9.4K sh · $39.79K
Blackrock Inc.
5.1K sh · $1.64K
Morgan Stanley
3.6K sh · $19.32K

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
10 PERCENT OWNER
Exicure HiTron Inc.
Purchase · 117.4K shares
2026-07-08
★
10 PERCENT OWNER
Exicure HiTron Inc.
Purchase · 253.2K shares
2026-06-26
★
10 PERCENT OWNER
Exicure HiTron Inc.
Purchase · 123.5K shares
2026-06-24
★
10 PERCENT OWNER
Exicure HiTron Inc.
Purchase · 129.2K shares
2026-06-23

SECTORS PEERS

PEERPRICE
RLYB$16.81COMPARE
NRXS$6.00COMPARE
TAOX$3.89COMPARE
IBIO$1.36COMPARE
NRSN$0.42COMPARE
CVKD$1.54COMPARE
CLGN$0.36COMPARE
MTVA$1.70COMPARE